Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice C Wei

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
The Lancet. Healthy Longevity|November 29, 2025
Significant new disability after major non-cardiac surgery in older adults aged 65 years and older in Canada: a multicentre prospective cohort studyDuminda N Wijeysundera, Shabbir M H Alibhai, Martine T E Puts, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
The New England Journal of Medicine|December 22, 2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Pascal Hammel, Mohamed Hebbar, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
JAMA Surgery|September 11, 2024
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection PrognosticationBrett L Ecker, Kenneth Seier, Austin M Eckhoff, et al.
BJS Open|March 4, 2025
Inter-rater variability for the American Society of Anesthesiologists classification in patients undergoing hepato-pancreato-biliary surgery (MILESTONE-2): international survey among surgeons and anaesthesiologistsSimone Augustinus, Jasper P Sijberden, Matthanja Bieze, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
The Lancet. Healthy Longevity|November 29, 2025
Significant new disability after major non-cardiac surgery in older adults aged 65 years and older in Canada: a multicentre prospective cohort studyDuminda N Wijeysundera, Shabbir M H Alibhai, Martine T E Puts, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
The New England Journal of Medicine|December 22, 2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Pascal Hammel, Mohamed Hebbar, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
JAMA Surgery|September 11, 2024
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection PrognosticationBrett L Ecker, Kenneth Seier, Austin M Eckhoff, et al.
BJS Open|March 4, 2025
Inter-rater variability for the American Society of Anesthesiologists classification in patients undergoing hepato-pancreato-biliary surgery (MILESTONE-2): international survey among surgeons and anaesthesiologistsSimone Augustinus, Jasper P Sijberden, Matthanja Bieze, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Pageof 18